The Mechatronic Remote Physiotherapy System (MRPS) in Remote Stroke Rehabilitation
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorInstitute of Technology, Sligo
About this trial
The aim of this pilot trial is to examine and compare the safety and feasibility of enhanced Early Supported Discharge (ESD) through the Mechatronic Remote Physiotherapy System (MRPS) and traditional ESD after stroke.
The main questions this trial aims to answer are:
* Is enhanced ESD via the MRPS safe, feasible and significantly different compared to traditional ESD when administered to patients after stroke? * Do patients interact with and are they satisfied with the MRPS? * Is enhanced ESD cost-effective compared to traditional ESD? * Are there any adverse effects of the MRPS and what are the areas for further improvement?
Participants in the experimental group will receive enhanced ESD through the MRPS.
The intervention will be given for approximately 6-8 weeks in total. Frequency will be determined by how often the participants' use the MRPS themselves. Frequency of use and level of completion of each session will be monitored. Enhanced ESD therapy sessions will be designed to reflect traditional ESD sessions.
Participants in the control group will receive traditional ESD. The intervention will be given for approximately 6-8 weeks in total with a frequency of 1-3 therapy visits per week (as per traditional ESD). Therapy sessions will be designed by therapists delivering the ESD service.
Eligibility criteria
Qualifiers
A clinical diagnosis of stroke;
Completed inpatient rehabilitation;
A level of ability that would allow them to participate safely (as determined by ESD team);
Cognitive ability to consent and take part;
Disqualifiers
Involvement in other studies or rehabilitation programmes;
A level of disability that would prevent them from participating safely (as determined by ESD team);
Low level technological literacy or resources (e.g. Wi-Fi) which would prevent access to MRPS platform;
Have uncontrolled medical condition or another serious medication condition in addition to stroke;
Trial design
Treatments tested in this trial
- Mechatronic Remote Physiotherapy System (MRPS)
- Early Supported Discharge
Treatment groups
14 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Institute of Technology, Sligo
Lead sponsor
Sligo General Hospital
Collaborator
Source ClinicalTrials.gov